Couverture de MDA Quest Podcast

MDA Quest Podcast

MDA Quest Podcast

De : Muscular Dystrophy Association
Écouter gratuitement

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
The official podcast for the Muscular Dystrophy Association2021 Muscular Dystrophy Association Développement personnel Hygiène et vie saine Maladie et pathologies physiques Réussite personnelle Sciences sociales
Épisodes
  • 69: Episode 67 - A Conversation with Steve Way, Part 2: Medicaid, Self-Advocacy, and the Life You Want

    69: Episode 67 - A Conversation with Steve Way, Part 2: Medicaid, Self-Advocacy, and the Life You Want
    Oct 7 2026

    In this episode of Quest Podcast, actor, comedian, and disability advocate Steve Way returns to continue our conversation, this time getting even more personal about his own reliance on home and community-based services and what independence really requires. Steve explains how these services make everything possible, from getting out of bed to doing his job, why the Medicaid cuts some states are facing are so frightening, and his practical tip for making sense of dense budget bills and Medicaid code. He also talks about picking your battles when energy is limited, why keeping your contact information current with your Medicaid office matters more than ever, and how a public speaking career that began at age nine grew into using his platform from Ramy and Furious to raise awareness for the disability community. Steve shares his experiences, expertise, and candid, no-nonsense perspective on self-advocacy, the fight for healthcare, and creating the life you want instead of waiting for it.

    Transcript

    Guests:

    Steve Way is a 35-year-old actor, comedian, writer, and speaker. He was born with Ullrich congenital muscular dystrophy and is an advocate for disability awareness. Steve performs stand-up comedy and motivational speeches around the country. He's known for his role as Steve on the Hulu show Ramy, and can now also be seen as Alden in Liz Meriwether's Hulu thriller series Furious, alongside Lola Petticrew — a role that's earned him praise for showing a different, more dramatic side of his range. Off screen, Steve is a strong advocate by writing and speaking publicly on disability justice, healthcare policy, and workers’ rights.

    Connect with Steve:

    • Instagram: @thesteveway
    • Website: www.thesteveway.com
    • SubStack: https://thesteveway.substack.com/

    Host:

    Mindy Henderson is MDA's Vice President of Disability Outreach & Empowerment, Editor-in-Chief of Quest Media, and the host of this podcast. She was diagnosed with spinal muscular atrophy (SMA) type 2, when she was 15 months old and has been a life-long partner to MDA. Mindy is also a professional speaker and author of the book, The Truth About Things That Suck.

    Connect with Mindy:

    • LinkedIn: https://www.linkedin.com/in/hendersonmindy/
    • Instagram: https://www.instagram.com/mindyhendersonspeaks/

    Afficher plus Afficher moins
    21 min
  • 68: Episode 66: More CMT Clinical Trials Than Ever Before: Inside the Research Turning Point

    68: Episode 66: More CMT Clinical Trials Than Ever Before: Inside the Research Turning Point
    Sep 19 2026
    In this episode of Quest Podcast, we chat with Sue Bruhn, PhD, CEO of the Charcot-Marie-Tooth Association (CMTA); Stephan Züchner, MD, PhD, Chief Genomics Officer at the University of Miami Miller School of Medicine; and Brian Lin, PhD, Senior Research Portfolio Director at the Muscular Dystrophy Association. Together, they break down what Charcot-Marie-Tooth disease (CMT) does to the peripheral nerves, why more than 100 different genes can cause it, and what separates a clinical diagnosis from a genetic one. They open up about the parts of living with CMT that research can overlook, from fatigue to the weight of seeing your own future in an older relative with CMT, and walk through the therapies now being tested, what the field has learned from trials that fell short, and how patients can get trial-ready today. Sue, Stephan, and Brian share their experiences, expertise, and genuine optimism about where CMT treatment is headed.Remember to register for the CMTA Patient & Research Summit, the association’s largest annual gathering of patients, families, researchers, and industry partners, taking place October 9–11 in San Francisco; you can register at https://give.cmtausa.org/event/cmta-patient-and-research-summit/e769535.TranscriptGuests:Sue Bruhn, PhD, has dedicated her career to patient-focused drug development for the treatment of rare diseases. She spent decades in biotech and has seen multiple products advance from research through clinical development and into the marketplace. She believes deeply in the power of patient communities and is proud to lead the CMTA, the largest philanthropic funder of CMT research and the provider of the most CMT patient services in the world.Sue is a scientist by training, with a degree in chemistry from Iowa State University and a PhD from MIT. Before joining CMTA, she held numerous executive leadership roles in pharmaceutical and biotech companies, including serving as CEO several times.She loves to travel, especially to visit her two adult sons. She lives in New Hampshire with her husband, Mike, and their dog, Brady.Connect with Sue:Facebook: https://www.facebook.com/CMTAssociation Instagram: https://www.instagram.com/cmtausa/ TikTok: https://www.tiktok.com/@cmtausa LinkedIn: https://www.linkedin.com/company/charcot-marie-tooth-association/ Dr. Stephan Züchner, M.D., Ph.D., is a Professor of Human Genetics and Neurology in the role of Chief Genomics Officer at the University of Miami Miller School of Medicine. He received his degrees from the University RWTH Aachen, Germany and an honorary doctoral degree from the Semmelweis Medical School in Budapest. His research interests are focused on identifying strong genetic variation associated with disease. His lab has been involved in identifying over 100 neuromuscular disease genes, such as the MFN2, SARM1, and SORD. More recently he has made significant contributions to repeat expansion disorders, helping to discover RFC1, FGF14, ABCD3 and other loci. His lab also works on basic mechanisms and the genome biology of short tandem repeat loci. To further enhance the ability to identify pathogenic variation, his team has recently developed machine learning and AI tools that have successfully supported disease gene identification. All this is directed towards the genomics-to-therapy concept, whereby progress in genomics will directly, and at times rapidly, lead to therapeutic options to be tested in clinical trials. He also leads the GENESIS genome database and has leadership and advisory roles ClinGen, UDN/UDN-Foundation, CMT Association, All of Us Research Project, and Muscular Dystrophy Association.Connect with Dr. Züchner: Twitter (X): https://x.com/szuchner https://www.tgp-foundation.org/ Brian Lin, PhD, serves as Senior Research Portfolio Director at the Muscular Dystrophy Association (MDA), where he oversees the organization’s research investments across the spectrum of neuromuscular diseases. He earned his Ph.D. from the University of Maryland, Baltimore, where he investigated disease mechanisms in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). He later completed postdoctoral training at the U.S. Food and Drug Administration (FDA), focusing on the genetic engineering of protein therapeutics and gene therapy platforms. Leveraging his multidisciplinary background spanning neuroscience and regulatory science, he now guides MDA’s efforts to advance transformative research and accelerate the translation of innovative therapies from the bench to the clinic for the neuromuscular disease community.Host:Mindy Henderson is MDA's Vice President of Disability Outreach & Empowerment, Editor-in-Chief of Quest Media, and the host of this podcast. She was diagnosed with spinal muscular atrophy (SMA) type 2, when she was 15 months old and has been a life-long partner to MDA. Mindy is also a professional speaker and author of the book, The Truth About Things That Suck.Connect with Mindy:LinkedIn:...
    Afficher plus Afficher moins
    54 min
  • 67: Episode 66 - A Conversation with Steve Way, Part 1: Inside Hulu’s Furious

    67: Episode 66 - A Conversation with Steve Way, Part 1: Inside Hulu’s Furious
    Sep 16 2026

    In this Quest Podcast episode, we sit down with actor, comedian, and disability advocate Steve Way, currently starring as Alden in Hulu's hit thriller Furious. Steve talks about how the role was written for him after a chance meeting with creator Liz Meriwether on a panel about caregiving in media, the freedom he had to improvise on set, and what it meant to finally portray a romantic disabled relationship on screen He's equally candid about where Hollywood still gets representation wrong, and why the attention he's getting now can't stop with him. Steve shares his experiences, expertise, and heartfelt perspective on visibility, artistic risk, and what strength looks like when you want to quit.

    Transcript

    Guests:

    Steve Way is a 35-year-old actor, comedian, writer, and speaker. He was born with Ullrich congenital muscular dystrophy and is an advocate for disability awareness. Steve performs stand-up comedy and motivational speeches around the country. He's known for his role as Steve on the Hulu show Ramy, and can now also be seen as Alden in Liz Meriwether's Hulu thriller series Furious, alongside Lola Petticrew — a role that's earned him praise for showing a different, more dramatic side of his range. Off screen, Steve is a strong advocate by writing and speaking publicly on disability justice, healthcare policy, and workers’ rights.

    Connect with Steve:

    • Instagram: @thesteveway
    • Website: https://www.thesteveway.com/
    • SubStack: https://thesteveway.substack.com/

    Host:

    Mindy Henderson is MDA's Vice President of Disability Outreach & Empowerment, Editor-in-Chief of Quest Media, and the host of this podcast. She was diagnosed with spinal muscular atrophy (SMA) type 2, when she was 15 months old and has been a life-long partner to MDA. Mindy is also a professional speaker and author of the book, The Truth About Things That Suck.

    Connect with Mindy:

    • LinkedIn: https://www.linkedin.com/in/hendersonmindy/
    • Instagram: https://www.instagram.com/mindyhendersonspeaks/
    Afficher plus Afficher moins
    21 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment